University Hospital of North Norway — Tromsø

Public research footprint of University Hospital of North Norway, compiled from the ClinicalTrials.gov public registry.

195

Registered studies

Active

Recruiting now

102

Completed

Stopped or withdrawn

Most-studied conditions

Platinum-resistant Ovarian Cancer · Alzheimer s Disease · Progressive Multiple Sclerosis · Atrial Fibrillation (AF)

Recently updated registry entries

NCT04634877 — Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or… (Active Not Recruiting)
NCT03889743 — Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time… (Recruiting)
NCT06855121 — The Norwegian Immunotherapy in Multiple Myeloma Study (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospital of North Norway?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.